JAGX vs TFX · rev $1.2M vs P/E 2083, rev $1.12B
Jaguar Animal Health Inc (JAGX) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Jaguar Animal Health Inc (JAGX) is a biotechnology company listed on NASDAQ.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported JAGX revenue for 2026-06-30 was $1.2M. Net income was -$12.8M. Revenue was down 94.0% from 2026-03-31 to 2026-06-30. JAGX currently screens at market cap $1.7M.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
JAGX currently screens at market cap $1.7M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the JAGX and TFX stock pages for the full models.
Not investment advice.